Publicité
La bourse est fermée
  • CAC 40

    8 205,81
    +1,00 (+0,01 %)
     
  • Euro Stoxx 50

    5 083,42
    +1,68 (+0,03 %)
     
  • Dow Jones

    39 807,37
    +47,29 (+0,12 %)
     
  • EUR/USD

    1,0791
    -0,0002 (-0,02 %)
     
  • Gold future

    2 254,80
    +16,40 (+0,73 %)
     
  • Bitcoin EUR

    65 045,31
    -407,14 (-0,62 %)
     
  • CMC Crypto 200

    885,54
    0,00 (0,00 %)
     
  • Pétrole WTI

    83,11
    -0,06 (-0,07 %)
     
  • DAX

    18 492,49
    +15,40 (+0,08 %)
     
  • FTSE 100

    7 952,62
    +20,64 (+0,26 %)
     
  • Nasdaq

    16 379,46
    -20,06 (-0,12 %)
     
  • S&P 500

    5 254,35
    +5,86 (+0,11 %)
     
  • Nikkei 225

    40 369,44
    +201,37 (+0,50 %)
     
  • HANG SENG

    16 541,42
    +148,58 (+0,91 %)
     
  • GBP/USD

    1,2616
    -0,0006 (-0,05 %)
     

Global Primary Cells Industry

Global Primary Cells Market to Reach US$1. 3 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Primary Cells estimated at US$775. 5 Million in the year 2020, is projected to reach a revised size of US$1.

New York, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Primary Cells Industry" - https://www.reportlinker.com/p05959781/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 7.1% over the period 2020-2027.Human Primary Cells, one of the segments analyzed in the report, is projected to grow at a 7.5% CAGR to reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Animal Primary Cells segment is readjusted to a revised 5.7% CAGR for the next 7-year period. This segment currently accounts for a 21.6% share of the global Primary Cells market.

The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 6.6% CAGR for the Period of 2020-2027

The Primary Cells market in the U.S. is estimated at US$229.2 Million in the year 2020. The country currently accounts for a 29.55% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$219.1 Million in the year 2027 trailing a CAGR of 6.6% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR while Rest of European market (as defined in the study) will reach US$219.1 Million by the year 2027.We bring years of research experience to this 5th edition of our report. The 175-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Allcells LLC

  • American Type Culture Collection (ATCC)

  • Axol Bioscience Ltd.

  • Cell Biologics, Inc.

  • Lonza Group AG

  • Merck KgaA

  • Promocell GmbH

  • Thermo Fisher Scientific, Inc.

  • Zenbio, Inc.




Read the full report: https://www.reportlinker.com/p05959781/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Primary Cells Competitor Market Share Scenario Worldwide
(in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Primary Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 2: World Historic Review for Primary Cells by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017

Table 3: World 15-Year Perspective for Primary Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2018 & 2027

Table 4: World Current & Future Analysis for Human Primary
Cells by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 5: World Historic Review for Human Primary Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 6: World 15-Year Perspective for Human Primary Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 7: World Current & Future Analysis for Animal Primary
Cells by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 8: World Historic Review for Animal Primary Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 9: World 15-Year Perspective for Animal Primary Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 10: World Current & Future Analysis for Life Science
Research Companies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2018 through 2027

Table 11: World Historic Review for Life Science Research
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 12: World 15-Year Perspective for Life Science Research
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2018 & 2027

Table 13: World Current & Future Analysis for Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2018 through
2027

Table 14: World Historic Review for Research Institutes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 15: World 15-Year Perspective for Research Institutes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Primary Cells Market Share (in %) by Company: 2018 & 2027
Market Analytics
Table 16: USA Current & Future Analysis for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 17: USA Historic Review for Primary Cells by Type - Human
Primary Cells and Animal Primary Cells Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 18: USA 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells and
Animal Primary Cells for the Years 2012, 2018 & 2027

Table 19: USA Current & Future Analysis for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 20: USA Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 21: USA 15-Year Perspective for Primary Cells by End-Use -
Percentage Breakdown of Value Sales for Life Science Research
Companies and Research Institutes for the Years 2012, 2018 &
2027

CANADA
Table 22: Canada Current & Future Analysis for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 23: Canada Historic Review for Primary Cells by Type -
Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 24: Canada 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells
and Animal Primary Cells for the Years 2012, 2018 & 2027

Table 25: Canada Current & Future Analysis for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 26: Canada Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 27: Canada 15-Year Perspective for Primary Cells by
End-Use - Percentage Breakdown of Value Sales for Life Science
Research Companies and Research Institutes for the Years 2012,
2018 & 2027

JAPAN
Table 28: Japan Current & Future Analysis for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 29: Japan Historic Review for Primary Cells by Type -
Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 30: Japan 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells and
Animal Primary Cells for the Years 2012, 2018 & 2027

Table 31: Japan Current & Future Analysis for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 32: Japan Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 33: Japan 15-Year Perspective for Primary Cells by
End-Use - Percentage Breakdown of Value Sales for Life Science
Research Companies and Research Institutes for the Years 2012,
2018 & 2027

CHINA
Table 34: China Current & Future Analysis for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 35: China Historic Review for Primary Cells by Type -
Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 36: China 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells and
Animal Primary Cells for the Years 2012, 2018 & 2027

Table 37: China Current & Future Analysis for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 38: China Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 39: China 15-Year Perspective for Primary Cells by
End-Use - Percentage Breakdown of Value Sales for Life Science
Research Companies and Research Institutes for the Years 2012,
2018 & 2027

EUROPE
Market Facts & Figures
European Primary Cells Market: Competitor Market Share Scenario
(in %) for 2018 & 2027
Market Analytics
Table 40: Europe Current & Future Analysis for Primary Cells by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2018 through 2027

Table 41: Europe Historic Review for Primary Cells by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 42: Europe 15-Year Perspective for Primary Cells by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2018 & 2027

Table 43: Europe Current & Future Analysis for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 44: Europe Historic Review for Primary Cells by Type -
Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 45: Europe 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells
and Animal Primary Cells for the Years 2012, 2018 & 2027

Table 46: Europe Current & Future Analysis for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 47: Europe Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 48: Europe 15-Year Perspective for Primary Cells by
End-Use - Percentage Breakdown of Value Sales for Life Science
Research Companies and Research Institutes for the Years 2012,
2018 & 2027

FRANCE
Table 49: France Current & Future Analysis for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 50: France Historic Review for Primary Cells by Type -
Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 51: France 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells
and Animal Primary Cells for the Years 2012, 2018 & 2027

Table 52: France Current & Future Analysis for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 53: France Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 54: France 15-Year Perspective for Primary Cells by
End-Use - Percentage Breakdown of Value Sales for Life Science
Research Companies and Research Institutes for the Years 2012,
2018 & 2027

GERMANY
Table 55: Germany Current & Future Analysis for Primary Cells
by Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 56: Germany Historic Review for Primary Cells by Type -
Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 57: Germany 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells
and Animal Primary Cells for the Years 2012, 2018 & 2027

Table 58: Germany Current & Future Analysis for Primary Cells
by End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 59: Germany Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2017

Table 60: Germany 15-Year Perspective for Primary Cells by
End-Use - Percentage Breakdown of Value Sales for Life Science
Research Companies and Research Institutes for the Years 2012,
2018 & 2027

ITALY
Table 61: Italy Current & Future Analysis for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 62: Italy Historic Review for Primary Cells by Type -
Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 63: Italy 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells and
Animal Primary Cells for the Years 2012, 2018 & 2027

Table 64: Italy Current & Future Analysis for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 65: Italy Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 66: Italy 15-Year Perspective for Primary Cells by
End-Use - Percentage Breakdown of Value Sales for Life Science
Research Companies and Research Institutes for the Years 2012,
2018 & 2027

UNITED KINGDOM
Table 67: UK Current & Future Analysis for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 68: UK Historic Review for Primary Cells by Type - Human
Primary Cells and Animal Primary Cells Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 69: UK 15-Year Perspective for Primary Cells by Type -
Percentage Breakdown of Value Sales for Human Primary Cells and
Animal Primary Cells for the Years 2012, 2018 & 2027

Table 70: UK Current & Future Analysis for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 71: UK Historic Review for Primary Cells by End-Use -
Life Science Research Companies and Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 72: UK 15-Year Perspective for Primary Cells by End-Use -
Percentage Breakdown of Value Sales for Life Science Research
Companies and Research Institutes for the Years 2012, 2018 &
2027

REST OF EUROPE
Table 73: Rest of Europe Current & Future Analysis for Primary
Cells by Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 74: Rest of Europe Historic Review for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 75: Rest of Europe 15-Year Perspective for Primary Cells
by Type - Percentage Breakdown of Value Sales for Human Primary
Cells and Animal Primary Cells for the Years 2012, 2018 & 2027

Table 76: Rest of Europe Current & Future Analysis for Primary
Cells by End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 77: Rest of Europe Historic Review for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017

Table 78: Rest of Europe 15-Year Perspective for Primary Cells
by End-Use - Percentage Breakdown of Value Sales for Life
Science Research Companies and Research Institutes for the
Years 2012, 2018 & 2027

ASIA-PACIFIC
Table 79: Asia-Pacific Current & Future Analysis for Primary
Cells by Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 80: Asia-Pacific Historic Review for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 81: Asia-Pacific 15-Year Perspective for Primary Cells by
Type - Percentage Breakdown of Value Sales for Human Primary
Cells and Animal Primary Cells for the Years 2012, 2018 & 2027

Table 82: Asia-Pacific Current & Future Analysis for Primary
Cells by End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 83: Asia-Pacific Historic Review for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017

Table 84: Asia-Pacific 15-Year Perspective for Primary Cells by
End-Use - Percentage Breakdown of Value Sales for Life Science
Research Companies and Research Institutes for the Years 2012,
2018 & 2027

REST OF WORLD
Table 85: Rest of World Current & Future Analysis for Primary
Cells by Type - Human Primary Cells and Animal Primary Cells -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 86: Rest of World Historic Review for Primary Cells by
Type - Human Primary Cells and Animal Primary Cells Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 87: Rest of World 15-Year Perspective for Primary Cells
by Type - Percentage Breakdown of Value Sales for Human Primary
Cells and Animal Primary Cells for the Years 2012, 2018 & 2027

Table 88: Rest of World Current & Future Analysis for Primary
Cells by End-Use - Life Science Research Companies and Research
Institutes - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 89: Rest of World Historic Review for Primary Cells by
End-Use - Life Science Research Companies and Research
Institutes Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017

Table 90: Rest of World 15-Year Perspective for Primary Cells
by End-Use - Percentage Breakdown of Value Sales for Life
Science Research Companies and Research Institutes for the
Years 2012, 2018 & 2027

IV. COMPETITION
Total Companies Profiled: 54
Read the full report: https://www.reportlinker.com/p05959781/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001